Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|July 17, 2016
αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4Zhao-Hui Jin, Takako Furukawa, Mélissa Degardin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 10, 2013
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivoZhao-Hui Jin, Takako Furukawa, Chizuru Sogawa, et al.
Chemical Communications (Cambridge, England)|June 23, 2015
Hydroxylamine-O-sulfonamide is a versatile lead compound for the development of carbonic anhydrase inhibitorsAnna Di Fiore, Alessandro Vergara, Marco Caterino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2020
Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian CancerZhao-Hui Jin, Atsushi B Tsuji, Mélissa Degardin, et al.
Organic Letters|April 7, 2018
Diastereoselective Synthesis of a Dyn[3]arene with Distinct Binding Behaviors toward Linear Biogenic PolyaminesMarion Donnier-Maréchal, Jean Septavaux, Emeric Jeamet, et al.
Chemical Communications (Cambridge, England)|October 11, 2016
Benzoxaborole as a new chemotype for carbonic anhydrase inhibitionVincenzo Alterio, Roberta Cadoni, Davide Esposito, et al.
The Journal of Organic Chemistry|December 23, 2015
On-Demand Cyclophanes: Substituent-Directed Self-Assembling, Folding, and BindingPierre-Thomas Skowron, Melissa Dumartin, Emeric Jeamet, et al.
ACS Omega|February 10, 2025
Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD PeptideZhao-Hui Jin, Mélissa Degardin, Takako Furukawa, et al.
Pageof 19